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Abstract
Introduction: The massive-transfusion concept was introduced to recognize the dilutional complications resulting
from large volumes of packed red blood cells (PRBCs). Definitions of massive transfusion vary and lack supporting
clinical evidence. Damage-control resuscitation regimens of modern trauma care are targeted to the early
correction of acute traumatic coagulopathy. The aim of this study was to identify a clinically relevant definition of
trauma massive transfusion based on clinical outcomes. We also examined whether the concept was useful in that
early prediction of massive transfusion requirements could allow early activation of blood bank protocols.
Methods: Datasets on trauma admissions over a 1 or 2-year period were obtained from the trauma registries of
five large trauma research networks. A fractional polynomial was used to model the transfusion-associated
probability of death. A logistic regression model for the prediction of massive transfusion, defined as 10 or more
units of red cell transfusions, was developed.
Results: In total, 5,693 patient records were available for analysis. Mortality increased as transfusion requirements
increased, but the model indicated no threshold effect. Mortality was 9% in patients who received none to five
PRBC units, 22% in patients receiving six to nine PRBC units, and 42% in patients receiving 10 or more units. A
logistic model for prediction of massive transfusion was developed and validated at multiple sites but achieved
only moderate performance. The area under the receiver operating characteristic curve was 0.81, with specificity of
only 50% at a sensitivity of 90% for the prediction of 10 or more PRBC units. Performance varied widely at different
trauma centers, with specificity varying from 48% to 91%.
Conclusions: No threshold for definition exists at which a massive transfusion specifically results in worse
outcomes. Even with a large sample size across multiple trauma datasets, it was not possible to develop a
transportable and clinically useful prediction model based on available admission parameters. Massive transfusion
as a concept in trauma has limited utility, and emphasis should be placed on identifying patients with massive
hemorrhage and acute traumatic coagulopathy.
Introduction
Hemorrhage is responsible for more than 40% of all
trauma deaths and therefore represents an important
target for improving outcomes after severe injury. The
concept of massive transfusion has existed for more
than half a century and was developed to highlight the
dilutional complications occurring when administering
large volumes of packed red blood cells (PRBCs) or
other fluids, which could be addressed by the use of
massive-transfusion protocols. Such protocols are not
immediately activated but typically require either the
presence of abnormal laboratory tests of coagulation
[1,2] or the prior administration of a certain number of
units of PRBCs [3].
It is now clear that standard massive-transfusion algo-
rithms are less effective in trauma hemorrhage [4,5]. Pri-
marily, this is due to the presence of an endogenous
coagulopathy very early in the clinical course of trauma
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patients, due to the presence of shock and tissue hypo-
perfusion [6]. This acute traumatic coagulopathy (ATC)
may be established by the time the patient arrives in the
emergency department [7-10] and is strongly associated
with the need for large volumes of blood transfusion [10].
New damage-control resuscitation protocols targeted at
ATC call for earlier plasma and blood-component regi-
mens [11], and significant improvements in outcome
may be achievable with such strategies [12-14].
In the absence of validated near-patient diagnostic
tools for ATC, some centers are moving to empiric
transfusion protocols activated early on the basis of clin-
ical judgment [3]. Prediction models for massive transfu-
sion have been developed in both civilian [15-17] and
military [18-20] settings, although in general, these pub-
lished tools have only moderate performance. In clinical
use, where sensitivity rates of more than 90% would be
important, these tools have very low specificities of
around 50%. These models were developed in specific
populations and remain largely unvalidated outside of
their original datasets.
We designed this international multicenter study to
reappraise the utility of massive transfusion as a clinical
concept in modern trauma care. The first aim of the
study was to assess whether a clinically relevant defini-
tion of massive transfusion existed in terms of a clinical
outcome. The second aim was to assess by predictive
modeling whether transfusion therapy can be rapidly
and appropriately instituted by using parameters poten-
tially available on trauma center admission.
Materials and methods
Datasets on trauma admissions were obtained from the
trauma registries of a research network of major trauma
centers. Participating trauma centers were the Royal
London Hospital, London, UK; Oslo University Hospital
Ulleval, Norway; Academic Medical Centre, Amsterdam,
the Netherlands; and San Francisco General Hospital,
San Francisco, California, USA. Data from The Trauma
Registry of the Deutsche Gesellschaft für Unfallchirurgie
(TR-DGU) [21,22] from Germany, which covers more
than 100 hospitals, were also included. The datasets
included information over a 1-year period (2007) except
the Oslo dataset covering 2 years (from June 2005). The
data included patient age, sex, penetrating injury (yes/
no), time from injury to emergency department arrival,
admission systolic blood pressure, base deficit, pro-
thrombin time (PT) and Injury Severity Score (ISS) [23],
number of packed red blood cells (PRBCs) transfused in
the first 24 hours, and in-hospital or 30 day (Oslo) mor-
tality. The authors confirm that each trauma registry of
the network is approved by a local review board and is
in compliance with the institutional and/or national
legal frameworks and data-protection requirements.
Informed consent was not required, according to institu-
tional, local and national guidelines. All data collection
and analysis was performed anonymously.
A fractional polynomial was used to relate the odds of
death to PRBCs received by logistic regression; these
polynomials allow great flexibility by combining combi-
nations of integer powers (such as squares and cubes)
and noninteger powers such as one-half (square root),
one third (cubic root), and others.
We then developed a logistic regression model for the
prediction of massive transfusion, defined as 10 or more
units of PRBCs. Missing data were a problem and were
dealt with by using multiple imputation by chained
equations [24,25] under the assumption of missing at
random [26]. Fifty imputed datasets were created (since
time to emergency department was unobserved in 42%
of patients) by using predictive mean matching, retain-
ing imputed values obtained after 100 cycles. The impu-
tation model was specified to be at least as complex as
the prognostic model [27], including all candidate pre-
dictors. Normalizing transformations of the observed
continuous variables were taken so that the distributions
of imputed and observed values were similar. All candi-
date predictors potentially available on admission and
thought to be associated with transfusion were consid-
ered. Center-specific effects were excluded to allow gen-
eralizability of results. Model parameters were estimated
by combining across imputed datasets [28]. Backward
elimination was used to select variables, with P > 0.1 as
the elimination criterion. A shrinkage factor was applied
to log odds ratios after model fitting before validation
[29]. The same model was also fitted by using complete
data without any imputation, to assess for any effects of
imputation. The results were consistent with the multi-
ple-imputation analysis, although the parameters were
estimated with greater precision with imputation (data
not shown). The Amsterdam data were not included in
this complete analysis without imputation, because time
to emergency department was not recorded at this
center.
Two training-validation dataset scenarios were used.
First, TR-DGU data from Germany were used for exter-
nal validation [30], with all other data used for training.
The German TR-DGU registry data contributed 1,705
patients, 30% of the total dataset, and was considered to
be of a suitable size for validation. Further, no data were
missing. As a second (internal) validation, data were
split randomly with 60% of patients from each center in
the training dataset and 40% in the validation dataset.
Calibration [31] and receiver operating characteristic
(ROC) plots were examined, along with sensitivity and
likelihood ratio, at 90% specificity. The calibration plot
was formed by predicting the likelihood of massive
transfusion for each patient in the validation dataset
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[32]. Individuals were then grouped by predicted prob-
ability, and these groups were compared with the
observed transfusions received. After validation, the
model was evaluated with the full dataset. We examined
between-center variation in the performance of the
model to investigate the effect of center-specific transfu-
sion practices. For these purposes, the model including
variables chosen from the previous two analyses was
fitted, and the predictive value was tested in each center
separately to see how variable this was. All statistical
analyses and graphics were produced in Stata version
10.1 (StataCorp, 4905 Lakeway Drive, College Station,
TX, USA).
Results
In total, 5,693 patient records were available for analysis.
Patient demographics, injury characteristics, admission
physiology, base deficit, and prothrombin times are
shown in Table 1. Records of 2,497 (44%) patients had a
complete set of observed covariates, whereas one covari-
ate was missing in 1,788 (31%) and two (14%) in 850.
Mortality increased as transfusion requirements
increased (Figure 1). No threshold effect was seen at
10 units or any other value of PRBC transfusions. Mor-
tality was 426 (9%) of 4,808 in patients who received
none to five PRBC units, 82 (22%) of 367 in patients
receiving six to nine PRBC units, and 217 (42%) of 518
in patients receiving 10 or more PRBC units. The frac-
tional polynomial model for transfusion-associated prob-
ability of death, adjusting for any institution effect, is
shown in Figure 2. The open dots above and below the
fitted line (deviance residuals) represent patients who
died (above) and survived (below). These serve to illus-
trate that transfusion for patients who died and survived
extends over the range of PRBC transfusions up to 30.
The model did not demonstrate any steps or plateaus:
each additional unit of blood transfused was associated
with an increased risk of death.
Table 2 reports the regression coefficients from the
logistic regression model. For the prediction of patients
requiring massive transfusion, transformation toward a
normal distribution for skewed continuous covariates
was undertaken, as shown in column 1, Table 2. Log-
odds and odds ratios for each variable are shown (log-
odds can be more readily added together to calculate
Table 1 Demographics
Number
missing
All patients
(n = 5,693)
London
(n = 788)
Oslo
(n = 2167)
San Francisco
(n = 384)
Amsterdam
(n = 649)
TR-DGU
(n = 1705)
Massive transfusion
cases (%)
0 518 (9%) 69 (9%) 68 (3%) 47 (12%) 12 (2%) 322 (19%)
Age in years
(range)
24 (0.4%) 36 (24 to 53) 33 (24 to 46) 34 (21 to 51) 40 (26 to 56) 33 (20 to 49) 41 (27 to 58)
Male (%) 0 4,161 (73%) 636 (81%) 1,539 (71%) 294 (77%) 451 (69%) 1,241 (73%)
Penetrating
injury (%)
23 (0.4%) 580 (10%) 150 (26%) 177 (8%) 125 (22%) 29 (5%) 99 (17%)
Injury Severity
Score (range)
86 (2%) 17 (9 to 29) 16 (6 to 26) 12 (5 to 22) 18 (10 to 29) 5 (1 to 15) 27 (18 to 38)
Systolic blood
pressure,
mean (SD)
(mm Hg)
425 (7%) 126 (29) 127 (30) 130 (32) 130 (32) 138 (26) 116 (29)
Base deficit, mean
(mM, range)
865 (15%) 2.3 (0.2 to 5.3) 2.6 (0.4 to 6.2) 1.2 (-0.6 to 3.4) 5.5 (3.0 to 9.3) 1.3 (-0.4 to 3.2) 3.4 (1.1 to 6.2)
Prothrombin time
(seconds, range)
1,648 (29%) 14.1 (13 to 16.8) 12.0 (12.0 to 13.2) 13.2 (13.2 to 15.6) 14.4 (13.5 to 15.5) 14.1 (13.4 to 14.8) 15.8 (13.0 to 21.0)
Time to
emergency
department
(minutes, range)
2,396 (42%) 56 (37-80) 62 (49 to 81) 47 (30 to 85) 27 (22 to 35) – 63 (48 to 85)
The Amsterdam dataset did not record time from injury to emergency department arrival, and coagulation data in the German TR-DGU registry were recorded as
Quick values for prothrombin time [39]. The Oslo dataset covers a 2-year period. TR-DGU, Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie.
Figure 1 Transfusion-related mortality. Mortality by packed red
blood cells (PRBCs) administered during the first 24 hours of
admission.
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patient-specific probability of massive transfusion, and
odds ratios are more meaningful for considering the
impact of an individual predictor). The variables with
the most weight in the model were systolic blood pres-
sure (Figure 3a), base deficit (Figure 3b) and prothrom-
bin time (Figure 3c). Age, penetrating injury, and time
to emergency department were also identified as impor-
tant dependent variables. Injury severity is known to be
related to transfusion requirements (Figure 3d), but
because accurate ISS scores are not directly available on
admission, these measures were excluded from the final
model, as shown. However, when a model including ISS
was fitted, it was found that ISS was a significant predic-
tor and gave more accurate predictions of massive trans-
fusion (data not shown). For continuous variables, the
odds ratios apply to a unit increase in the transformed
variable (for example, √age). A patient’s logit probability,
A, of transfusion could be calculated by summing the
intercept and appropriate log-odds ratios for their para-
meters by using Table 2. The probability of massive
transfusion was then calculated from
exp
exp
A
A
( )
+ ( )1 .
The receiver operating characteristic (ROC) curve is
shown in Figure 4a and has an area under the curve
(AUC) of 0.81, externally validated on the German TR-
DGU data. This model performed less well at intermedi-
ate and higher probabilities of 10+ PRBC transfusions
(Figure 4b). At a sensitivity of 90%, specificity for massive
transfusion was only 50%, with 58% of patients correctly
classified. For the internal validation (60 to 40 split), the
identical set of variables was selected; in this case, the
AUC was 0.89 (95% confidence interval, 0.87 to 0.92),
with a specificity of 70% at 90% sensitivity. The model
varied in performance when applied to specific trauma
centers. At a sensitivity of 90%, the specificity varied
from 48% (San Francisco) to 91% (Amsterdam). Com-
plete data analysis was entirely consistent with the multi-
ple imputation analysis in terms of parameter estimates
and confidence intervals (CIs). The only difference
was reflected in less-precise parameter estimates,
as would be expected. Because validation was on the
German TR-DGU centers, and these had no missing
data, the inferences were very similar to those using mul-
tiple imputation.
Discussion
This international multicenter study was conducted to
evaluate the clinical applicability of massive transfusion
as a concept in modern trauma care. The five trauma
datasets represent a range of sizes and activities, which
are likely to be generalizeable to many different trauma
units worldwide. Any definition of massive transfusion
should be useful in terms of its relevance to patient out-
come. We have shown an association between transfu-
sion and mortality, with a continuous increase in risk,
and with a steeper increase in the lower ranges of the
curve. We were not able to identify the traditional
10 units of PRBCs or any other specific threshold defini-
tion of massive transfusion, based on a mortality
Figure 2 Estimated probability of death per unit of packed red
blood cells (PRBCs) administered (95% confidence interval in
grey). Dots are deviance residuals. The band of dots above the line
represents patients who died; the band below is those who
survived.
Table 2 Regression coefficients from logistic regression model
Log-odds ratio (SEM) Odds ratio (95% CI)
√age 0.16 (0.05) 1.2 (1.1 to 1.3)
Ln (time to emergency department) 0.06 (0.17) 1.1 (0.8 to 1.5)
Penetrating injury 0.4 (0.24) 1.5 (0.9 to 2.4)
Systolic blood pressure -0.02 (0.003) 0.98 (0.97 to 0.98)
ln(25a + base deficit) 5.48 (0.5) 240 (91 to 639)
1/(ln(prothrombin time2)) -26.7 (4.3) 2.5 × 10-12 (5.3 × 10-16 to 1.2 × 10-8)
Intercept -16.7 (2.3) -
a25 is an arbitrary constant added to base deficit to ensure positive values before logarithmic transformation.
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outcome. Patients receiving six to nine units of PRBCs
had nearly 2.5 times the mortality of patients receiving
none to five units. Management strategies targeted at
patients receiving a threshold of 10 or more PRBC units
will exclude a large proportion of patients receiving
fewer transfusions but who still have a significant mor-
tality. Research studies examining only massively trans-
fused patients, according to this definition, will therefore
exclude an important patient group. Moreover, thera-
peutic intervention studies will be confounded by any
treatment effect that results in reduced PRBC require-
ments and therefore the inappropriate exclusion of
patients from the study population. This may be one
factor relevant to discussions about the internal validity
of retrospective reports suggesting benefit with increased
plasma and platelet transfusions in massively transfused
patients [12-14,33-35].
The utility of the massive-transfusion concept may
better apply for its therapeutic potential, and it may
have a role in the activation of major hemorrhage
protocols. Damage-control resuscitation strategies
require early administration of blood-component ther-
apy along with the first units of PRBCs [11], and
attempts have been made to develop prediction algo-
rithms for massive transfusion [15-20]. Our prediction
model has been robustly validated across multiple cen-
ters, a larger sample size, and a wider geographic area,
and uses variables that are potentially available soon
after arrival in the emergency department. However, the
performance of the model was only moderate, and the
AUC of our tool of 0.81 is consistent with other predic-
tion tools (0.68 to 0.85) [15-20]. Setting the sensitivity at
a clinically useful threshold of 90% (at which 10% of
actively bleeding patients will be missed initially), the
tool has a specificity of only 50%. [15-20]. The conse-
quences of lower specificity is the risk of inappropriate
activations of transfusion protocols, wasting of blood
products, and increased exposure of patients to adverse
events related to transfusion. The potentially harmful
effects of PRBCs in trauma patients, especially in
Figure 3 Scatterplots showing admission parameters and injury severity associated with transfusion requirements. Where covariates are
missing for patient data, an average of imputed values has been substituted. (a) Packed red blood cells (PRBCs) transfusions by admission
systolic blood pressure. (b) PRBC transfusions by admission base deficit. (c) PRBC transfusions by admission prothrombin time. (d) PRBC
transfusions by injury-severity score.
Stanworth et al. Critical Care 2010, 14:R239
http://ccforum.com/content/14/6/R239
Page 5 of 8
relation to storage age, have been documented [36]. This
will have increasing impact as protocols move toward
much higher doses of plasma, platelets, fibrinogen, and
cryoprecipitate.
One of the reasons for the difficulties in developing
any models with high specificity and sensitivity is likely
to be the heterogeneity in patient populations of trauma.
Existing transfusion practices may also limit its utility in
clinical practice. This study shows that the reliable pre-
diction of massive transfusion from standard admission
physiology alone is difficult. The components of the pre-
diction model were heavily weighted toward systolic
blood pressure, base deficit, and the prothrombin time,
which are the main features driving the development of
ATC [6].
The performance of the tool might be improved if a
better near-patient measure of the severity of the coagu-
lopathy were available (for example, functional tests of
coagulation such as thromboelastometry or thromboe-
lastography) [37,38]. Injury severity is also a strong
dependent variable for the prediction of ATC and mas-
sive transfusion [6-9], but is not immediately available.
Whether it is possible to develop an alternative but
comparable measure for ISS that is available soon after
admission remains unclear. Currently, no biomarkers of
tissue injury are available, but such a rapidly available
measure might also significantly improve prediction
algorithms for ATC, massive hemorrhage, and patient
care. Future work must look at these alternative
approaches to developing a clinically useful prediction
tool, because even across multiple datasets and with the
application of several validation techniques, this study
was not able to develop a reliable prediction tool.
Some limitations exist in this study. It is a retrospec-
tive review of registry data in which a variable propor-
tion of records contained missing data, but this is
inevitable to a degree in analyses of multiple registries.
Multiple imputation assumes that missing data are ran-
dom, having accounted for observed covariates, but this
may not have been the case if variables that predict
missing data were not recorded. However, the model
performed well against the German TR-DGU data,
which were more plentiful, indicating geographic trans-
portability [30]. Entry criteria for the datasets were also
recognized to be different. The San Francisco dataset
included only patients with a higher-level trauma team
activation, whereas the German TR-DGU included only
patients with an ISS of 9 or higher. It was not possible
to standardize the measurements of PT between the
centers, as different thromboplastins were used, each
with a different laboratory-specific Mean Normal Pro-
thrombin Time (MNPT) and International Specificity
Index (ISI), although in this study, the variations in
reference ranges and results for PT were small, and the
majority of results were normal or only marginally
increased [39].
The mortality model may also be confounded because,
as for patients dying within 24 hours, the rate of PRBC
transfusion may have been higher than indicated in the
data [40]. In addition, it is difficult to exclude an effect
due to censoring for death, as some patients may die
before sufficient time to receive blood. The rate of
bleeding is not available from standard registry data but
has been identified as an important confounder in the
retrospective high-dose plasma studies [3]. Another lim-
itation is the lack of information between centers on
indications for transfusing PRBCs, the variation in trans-
fusion practices, and the use of hemostatic drugs such
as antifibrinolytics or even recombinant activated factor
Figure 4 Performance of the massive-transfusion prediction
tool. The performance of the model developed on non-German
TR-DGU centers and validated on German TR-DGU registry data (see
text). (a) Receiver operating characteristic plot. Area under the ROC
curve, 0.81. (b) Calibration plot.
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VIIa [41]. Massive transfusion not only is the result of a
set of clinical parameters but it also is a function of the
clinical response to them.
Conclusions
In summary, current definitions of massive transfusion
are not supported by clinical outcomes and are not use-
ful for guiding management. Rather, mortality increases
with each PRBC unit required, although not linearly.
The robust prediction of massive transfusion from stan-
dard admission parameters remains difficult. The con-
cept of massive hemorrhage may be more useful than is
massive transfusion for modern trauma care. New
approaches are required for the early diagnosis of
patients with acute traumatic coagulopathy who are
actively bleeding and will go on to require significant
blood-component transfusions.
Key messages
• Red cell requirements in trauma correlate with
mortality.
• No clinically relevant threshold defines massive
transfusion in terms of clinical outcomes.
• Red cell transfusion requirements cannot reliably
be predicted on the basis of standard physiological
variables available on admission.
• Attention should be focused on identifying patients
with massive hemorrhage.
• New diagnostic modalities are needed for the early
identification of acute traumatic coagulopathy.
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